What you should know:
1. MedTech Outlook created the award to recognize companies excelling in their respective fields.
2. Epigenomics received the award for its noninvasive blood-based cancer diagnostic tests.
3. One such test, Epi proColon, is a blood-based colorectal cancer test. It is available in the U.S., Europe and China.
Epigenomics CEO Greg Hamilton said, “We believe that Epi proColon could help address the unmet medical need for new, noninvasive strategies for colorectal cancer detection.”
More articles on surgery centers:
ASCA selects partner for patient surveys
NewYork-Presbyterian children’s hospital earns level 1 surgery center status
4 Qs with Christine Mackey-Ross & Linda Komnick on tackling physician burnout
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
